Início › Linfoma de Burkitt › Texas › San Antonio
Ensaios clínicos de Linfoma de Burkitt em San Antonio, TX
7 estudos para Linfoma de Burkitt estão buscando participantes em locais em San Antonio e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RecrutandoFase 2
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RecrutandoFase 2
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
RecrutandoFase 1
- Methodist Children's Hospital, San Antonio
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecrutandoFase 2
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecrutandoFase 3
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
RecrutandoFase 1/2
- Sarah Cannon - Texas Transplant Institute at Methodist Hospital, San Antonio
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
RecrutandoFase 2
- Methodist Healthcare System, San Antonio
Ensaios de Linfoma de Burkitt em outras cidades
- Houston, TX21 estudos
- Milwaukee, WI16 estudos
- Philadelphia, PA16 estudos
- New York City, NY14 estudos
- Chicago, IL14 estudos
- Cincinnati, OH12 estudos
- Atlanta, GA12 estudos
- Seattle, WA11 estudos
- Durham, NC10 estudos
- Boston, MA10 estudos
- Los Angeles, CA10 estudos
- Aurora, CO10 estudos
Outros estudos em San Antonio
- Câncer de Pulmão de Não Pequenas Células59 estudos
- Câncer Colorretal46 estudos
- Câncer de Mama46 estudos
- Câncer Metastático44 estudos
- Câncer (todos os tipos)41 estudos
- Obesidade40 estudos
- Diabetes tipo 237 estudos
- Sobrepeso34 estudos
- Câncer de Ovário31 estudos
- Câncer de Pâncreas31 estudos
- Câncer de Próstata28 estudos
- Câncer Endometrial27 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.